Another marker expressed in a myriad of different cancers, ALDH1, might prove a useful therapeutic target due to its roles in modulating MYC, VEGF, and Wnt/β-catenin signaling pathways, and in conferring protection from ROS [78]. The gene discussed is MYC; the disease is cancer.